Biocryst Pharmaceuticals Inc (BCRX)
Cost of Revenue
$719.42M
TTM · Period ending: · USD
BCRX Cost of Revenue
Latest reported$719.42Mperiod ending
Latest reported$719.42Mperiod ending
BCRX TTM Cost of Revenue ($5.00M → $719.42M)
TTM cost of revenue
High-resolution chart · PNG
BCRX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 719,416,000 | |
| 718,374,000 | |
| 19,804,000 | |
| 16,019,000 | |
| 16,725,000 | |
| 15,626,000 | |
| 12,323,000 | |
| 7,829,000 | |
| 5,737,000 | |
| 4,988,000 | |
| 4,661,000 | |
| 5,520,000 | |
| 7,997,000 | |
| 7,294,000 | |
| 6,594,000 | |
| 4,517,000 | |
| 1,519,000 | |
| 1,615,000 | |
| 7,300,000 | |
| 6,962,000 | |
| 7,873,000 | |
| 7,530,000 | |
| 1,676,000 | |
| 4,166,000 | |
| 2,658,000 | |
| 2,684,000 | |
| 4,101,000 | |
| 1,600,000 | |
| 1,600,000 | |
| 1,817,000 | |
| 471,000 | |
| 530,000 | |
| 1,769,000 | |
| 1,548,000 | |
| 1,702,000 | |
| 4,025,000 | |
| 2,911,000 | |
| 2,916,000 | |
| 2,699,000 | |
| 275,000 | |
| 1,483,000 | |
| 1,898,000 | |
| 1,896,000 | |
| 1,912,000 | |
| 13,597,000 | |
| 13,160,000 | |
| 13,158,000 | |
| 13,131,000 | |
| 7,830,000 | |
| 7,829,000 | |
| 7,833,000 | |
| 7,834,000 | |
| 12,285,000 | |
| 12,281,000 | |
| 12,204,000 | |
| 12,186,000 | |
| 0 | |
| 0 | |
| 0 | |
| 459 | |
| 459 | |
| 459 | |
| 86,459 | |
| 4,629,914 | |
| 4,629,914 | |
| 4,629,914 | |
| 4,543,914 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 507,780 |